Skip to content
Home/Companies/Biotech/Immunic Therapeutics
IT

Immunic Therapeutics

Biotech·Germany·Exited 2019·Held 3yr

Immunic Therapeutics is a biotech company, headquartered in Germany.

Entry
2016
Hold
3yr
Exit
2019
Est. EV
–

Who owns Immunic Therapeutics?

Immunic Therapeutics was owned by bmp Ventures AG through IBG Innovationsfonds (2015 vintage) from 2016 to 2019, exited via IPO.

Hand-verified · updated 2026-07-03

bmp Ventures AG
Investor
bmp Ventures AG
IBG Innovationsfonds · 2015 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2019

More from IBG Innovationsfonds

Other portfolio companies in the same fund.

SimFin
Active
FintechGermany· 2022
Wingfield
Active
TMTGermany· 2022
neotiv
Active
HealthTechGermany· 2021
Paxly
Active
SoftwareGermany· 2021
SOLAR MATERIALS
Active
EnergyGermany· 2021
AUTOVIO
Active
TMTGermany· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings